Calumet, Inc.
NASDAQ:CLMTOil & Gas Exploration & Production
-$1.21 today
- Market cap
- $2.67B
- Beta
- 0.72
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$2.17
Volume 1.74M
Average 1.11M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Calumet, Inc.
NASDAQ:CLMT
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -4.1% | +7.5% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | -25.7% | +61.3% (5yr)2 analysts |
Analysis
Recent growth has been strongest in Revenue at -4.1% over three years. Forward estimates point to EBIT at +61.3% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
RPM International Inc. NYSE:RPM | $13.23B | $103.73 | Overvalued | 20.4 | +3.05% |
NewMarket Corporation NYSE:NEU | $6.52B | $709.19 | Undervalued | 17.5 | -5.42% |
Perimeter Solutions, Inc. NYSE:PRM | $4.81B | $29.36 | Overvalued | -29.3 | +13.05% |
Cabot Corporation NYSE:CBT | $3.69B | $71.92 | Undervalued | 16.3 | +26.18% |
Quaker Chemical Corporation NYSE:KWR | $2.67B | $155.43 | Overvalued | 611.4 | +21.91% |
Ingevity Corporation NYSE:NGVT | $2.08B | $61.72 | Undervalued | -20.0 | +20.20% |
The Chemours Company NYSE:CC | $2.00B | $13.29 | Fairly Valued | -8.0 | +13.95% |
Innospec Inc. NASDAQ:IOSP | $1.98B | $80.39 | Undervalued | 18.0 | +12.58% |
Stepan Company NYSE:SCL | $1.51B | $66.38 | Overvalued | -87.3 | +59.66% |
FutureFuel Corp. NYSE:FF | $127.20M | $2.90 | Overvalued | -3.6 | +1.33% |
Continue the stock analysis
Jump to another research area for this company.